The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and molecular features of resected breast cancer brain metastases: A retrospective cohort study.
 
Nira Krasnow
No Relationships to Disclose
 
Mia Salans
No Relationships to Disclose
 
Michelle Jayaraj
Employment - Yale New Haven Hospital (I)
Stock and Other Ownership Interests - Abbvie; Abbvie (I); Pfizer; Pfizer (I)
 
Kelsey Kuwahara
No Relationships to Disclose
 
Maggie Zhou
No Relationships to Disclose
 
Lauren Boreta
No Relationships to Disclose
 
Steve Braunstein
Employment - University of California, San Francisco
Consulting or Advisory Role - GT Medical Technologies; Icotec; Novocure
 
Manish Aghi
No Relationships to Disclose
 
Jo Chien
Consulting or Advisory Role - Genentech/Roche
Research Funding - Amgen (Inst); Merck (Inst); Olema Oncology (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Pending Patent Application for “COMBINATION INCLUDING A CPG-C TYPE OLIGONUCLEOTIDE AND A PD-1 ANTAGONIST FOR TREATING BREAST CANCER”
Travel, Accommodations, Expenses - Genentech/Roche
 
Hope Rugo
Honoraria - Chugai Pharma; Mylan/Viatris
Consulting or Advisory Role - Bristol Meyer; Napo Pharmaceuticals; Sanofi
Research Funding - Ambryx (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Gilead Sciences (Inst); Hoffmann-La Roche AG/Genentech, Inc (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Stemline Therapeutics (Inst)
 
Michelle Melisko
Stock and Other Ownership Interests - Merrimack (I)
Consulting or Advisory Role - Genentech
Speakers' Bureau - AstraZeneca (I); Daiichi Sankyo/Astra Zeneca (I); Gilead Sciences (I)
Research Funding - DAEHWA Pharmaceutical (Inst); OBI Pharma (Inst); Puma Biotechnology (Inst)
Patents, Royalties, Other Intellectual Property - Multiple patents related to immunoliposomal drugs being studied and potentially brought to market by Merrimack (I)
Expert Testimony - GlaxoSmithKline
 
Ramin Morshed
No Relationships to Disclose
 
Harish Vasudevan
Patents, Royalties, Other Intellectual Property - Lilly
 
Laura Huppert
Consulting or Advisory Role - AstraZeneca; Pfizer
Research Funding - Greenwich LifeSciences (Inst)
Patents, Royalties, Other Intellectual Property - Book royalties: McGraw Hill